Richard Feinn, PhD

  • 2Articles
  • 38.9KReads
  • 2016–2022Active
  • 7Collaborators
  • 79Citations

About

Richard Feinn, PhD, is affiliated with the School of Medicine at Quinnipiac University in Hamden, Connecticut. His publications in Psychiatrist.com focus on addiction and suicide, including studies on intravenous racemic ketamine for treatment-resistant depression and suicidal ideation, as well as the use of topiramate in managing heavy drinking. Feinn has collaborated frequently with co-authors such as Albert J. Arias and Henry R. Kranzler.

Publications

JCP
Intravenous Ketamine for Treatment-Resistant Depression
Original Research

Intravenous Ketamine for Treatment-Resistant Depression

September 12, 2022

The clinical effectiveness of ketamine for suicidal ideation and treatment-resistant depression outside of controlled clinical trials is unclear. This article reports clinical outcomes of a large cohort treated with...
, , , et al
JCP
Article

Balancing Risk and Benefit in Heavy Drinkers Treated With Topiramate: Implications for Personalized Care

March 23, 2016

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe